These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison. Hautmann S; Toma M; Lorenzo Gomez MF; Friedrich MG; Jaekel T; Michl U; Schroeder GL; Huland H; Juenemann KP; Lokeshwar VB Eur Urol; 2004 Oct; 46(4):466-71. PubMed ID: 15363562 [TBL] [Abstract][Full Text] [Related]
5. Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder. Feil G; Zumbrägel A; Päulgen-Nelde HJ; Hennenlotter J; Maurer S; Krause S; Bichler KH; Stenzl A Anticancer Res; 2003; 23(2A):963-7. PubMed ID: 12820331 [TBL] [Abstract][Full Text] [Related]
6. Immunocyt: a new tool for detecting transitional cell cancer of the urinary tract. Mian C; Pycha A; Wiener H; Haitel A; Lodde M; Marberger M J Urol; 1999 May; 161(5):1486-9. PubMed ID: 10210378 [TBL] [Abstract][Full Text] [Related]
7. ImmunoCyt a useful method in the follow-up protocol for patients with urinary bladder carcinoma. Olsson H; Zackrisson B Scand J Urol Nephrol; 2001 Sep; 35(4):280-2. PubMed ID: 11676352 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer. Gilbert SM; Veltri RW; Sawczuk A; Shabsigh A; Knowles DR; Bright S; O'Dowd GJ; Olsson CA; Benson MC; Sawczuk IS Urology; 2003 Mar; 61(3):539-43. PubMed ID: 12639642 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic efficacy of the ImmunoCyt test to detect superficial bladder cancer recurrence. Vriesema JL; Atsma F; Kiemeney LA; Peelen WP; Witjes JA; Schalken JA Urology; 2001 Sep; 58(3):367-71. PubMed ID: 11549482 [TBL] [Abstract][Full Text] [Related]
10. [ImmunoCyt--a new urine test in diagnosis of bladder cancer]. Feil G; Bichler KH; Päulgen-Nelde HJ; Hennenlotter J; Zumbrägel A; Stenzl A Urologe A; 2003 Apr; 42(4):531-7. PubMed ID: 12715125 [TBL] [Abstract][Full Text] [Related]
11. ImmunoCyt and cytokeratin 20 immunocytochemistry as adjunct markers for urine cytologic detection of bladder cancer: a prospective study. Li HX; Li M; Li CL; Ma JH; Wang MR; Rao J; Pan QJ Anal Quant Cytol Histol; 2010 Feb; 32(1):45-52. PubMed ID: 20701087 [TBL] [Abstract][Full Text] [Related]
12. Urinary beta-glucuronidase activity as an initial screening test for urinary tract malignancy in high risk patients. Comparison with conventional urine cytologic evaluation. Ho KJ; Kuo SH Cancer; 1995 Aug; 76(3):473-8. PubMed ID: 8625129 [TBL] [Abstract][Full Text] [Related]
13. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder. Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510 [TBL] [Abstract][Full Text] [Related]
14. Role of uCyt+ in the detection and surveillance of urothelial carcinoma. Lodde M; Mian C; Negri G; Berner L; Maffei N; Lusuardi L; Palermo S; Marberger M; Brssner C; Pycha A Urology; 2003 Jan; 61(1):243-7. PubMed ID: 12559316 [TBL] [Abstract][Full Text] [Related]
15. Urinary cytodiagnosis: can it have a different prognostic implication than a diagnostic test? Chow NH; Tzai TS; Cheng HL; Chan SH; Lin JS Urol Int; 1994; 53(1):18-23. PubMed ID: 7974880 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of voided urine and bladder barbotage cytology in detecting transitional cell carcinoma of the urinary tract. Konety BR; Metro MJ; Melham MF; Salup RR Urol Int; 1999; 62(1):26-30. PubMed ID: 10436427 [TBL] [Abstract][Full Text] [Related]
17. Fluorescence in situ hybridization assay detects upper urinary tract transitional cell carcinoma in patients with asymptomatic hematuria and negative urine cytology. Huang WT; Li LY; Pang J; Ruan XX; Sun QP; Yang WJ; Gao X Neoplasma; 2012; 59(4):355-60. PubMed ID: 22489689 [TBL] [Abstract][Full Text] [Related]
18. Analysis of atypical urine cytology in a tertiary care center. Deshpande V; McKee GT Cancer; 2005 Dec; 105(6):468-75. PubMed ID: 16080177 [TBL] [Abstract][Full Text] [Related]
19. ImmunoCyt/uCyt+ improves the sensitivity of urine cytology in patients followed for urothelial carcinoma. Têtu B; Tiguert R; Harel F; Fradet Y Mod Pathol; 2005 Jan; 18(1):83-9. PubMed ID: 15389253 [TBL] [Abstract][Full Text] [Related]
20. Comparison of urine cytology and fluorescence in situ hybridization in upper urothelial tract samples. Reynolds JP; Voss JS; Kipp BR; Karnes RJ; Nassar A; Clayton AC; Henry MR; Sebo TJ; Zhang J; Halling KC Cancer Cytopathol; 2014 Jun; 122(6):459-67. PubMed ID: 24604675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]